Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

BACKGROUND: Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19). Despite its use for treating several viral infections, we lack comprehensive data on its efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Sho, Kutsuna, Satoshi, Akifumi, Imamura, Hase, Ryota, Oda, Rentaro, Terada, Junko, Shimizu, Yosuke, Uemura, Yukari, Takamatsu, Yuki, Yasuhara, Akemi, Shiratori, Katsuyuki, Satake, Masahiro, Sakamoto, Naoya, Miyazaki, Yasunari, Shimizu, Hidefumi, Togano, Tomiteru, Matsunaga, Akihiro, Okuma, Kazu, Hamaguchi, Isao, Fujisawa, Kyoko, Nagashima, Maki, Ashida, Shinobu, Terada, Mari, Kimura, Akiko, Morioka, Shinichiro, Matsubayashi, Keiji, Tsuno, Nelson Hirokazu, Kojima, Makiko, Kuramitsu, Madoka, Tezuka, Kenta, Ikebe, Emi, Ishizaka, Yukihito, Kenji, Maeda, Hangaishi, Akira, Mikami, Ayako, Sugiura, Wataru, Ohmagari, Norio, Mitsuya, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174342/
https://www.ncbi.nlm.nih.gov/pubmed/37178973
http://dx.doi.org/10.1016/j.jiac.2023.05.012

Ejemplares similares

Ejemplares similares